The European Society of Cardiology (ESC) has released updated guidelines for cardiac pacing and cardiac resynchronization therapy (CRT), which emphasize patient-centered care and shared ...

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...

The FDA has approved a new Medtronic pacemaker that automatically adjusts heart failure patients' cardiac rhythms according to their needs. The cardiac resynchronization therapy-pacemaker, Viva CRT-P, ...

Boston Scientific has announced it has received FDA approval its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers, according to a news release. The INGENIO and ...

Boston Scientific is recalling Ingenio family of pacemakers (includes models Advantio DR EL, Ingenio DR EL, and Vitalio DR EL) and cardiac resynchronization therapy pacemakers (CRT-Ps) due to the risk ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

Cardiac pacemaker implantation is a primary therapy for various arrhythmic disorders; however, safety concerns persist in India. This study aimed to evaluate two-year safety outcomes of cardiac ...

BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and Israel Addressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart Failure This ...